Objective: Thymic carcinoma (TC) is a rare and invasive mediastinal tumor, with poor prognosis. Most of the previous published papers are single-institution based, reporting small series of patient, sometimes including palliative resection. This study collected patients with TC treated in 5 high-volume Italian Thoracic Surgery Institutions. Methods: A multicenter retrospective study of patients operated for TC between 2000 and 2011 was conducted. Exclusion criteria were: Neuroendocrine thymic neoplasms, debulking/palliative resection and tumor biopsy. Cause specific survival (CSS) was the primary endpoint. Results: Four hundred and seventy-eight patients underwent surgery for thymic malignancies: 40 of them (8.4%) had TC. Eleven (27.5%) received induction chemotherapy because of their radiological invasiveness. A complete resection (R0) was achieved in 36 (90%; 9/11 submitted to induction chemotherapy). Adjuvant radio/chemotherapy was offered to 37 patients, according to the type of surgical resection and tumor invasiveness. Three, 5 and 10-year survival rates were 79%, 75% and 58%. Recurrences developed in 10 patients. R0 resection (p<0.0003) and absence of tumor recurrences (p = 0.03) resulted significant prognostic factors at univariate analysis. Independent CSS predictor was the achievement of a complete resection (p<0.05). Conclusions: TC is a rare and invasive mediastinal tumor. A multimodal approach is indicated especially in TC invasive forms. The achievement of a complete surgical resection is fundamental to improve survival. (C) 2013 Elsevier Ireland Ltd. All rights reserved.

Outcome of surgically resected thymic carcinoma: A multicenter experience / Pier Luigi, Filosso; Francesco, Guerrera; Rendina, Erino Angelo; Angelo Erino, Rendina; Giulia, Bora; Enrico, Ruffini; Domenico, Novero; Ruco, Luigi; Domenico, Vitolo; Anile, Marco; Ibrahim, Mohsen; Caterina, Casadio; Ottavio, Rena; Arianna, Terzi; Paraskevas, Lyberis; Alberto, Oliaro; Venuta, Federico. - In: LUNG CANCER. - ISSN 0169-5002. - STAMPA. - 83:2(2014), pp. 205-210. [10.1016/j.lungcan.2013.11.015]

Outcome of surgically resected thymic carcinoma: A multicenter experience

RENDINA, Erino Angelo;RUCO, Luigi;ANILE, MARCO;IBRAHIM, MOHSEN;VENUTA, Federico
2014

Abstract

Objective: Thymic carcinoma (TC) is a rare and invasive mediastinal tumor, with poor prognosis. Most of the previous published papers are single-institution based, reporting small series of patient, sometimes including palliative resection. This study collected patients with TC treated in 5 high-volume Italian Thoracic Surgery Institutions. Methods: A multicenter retrospective study of patients operated for TC between 2000 and 2011 was conducted. Exclusion criteria were: Neuroendocrine thymic neoplasms, debulking/palliative resection and tumor biopsy. Cause specific survival (CSS) was the primary endpoint. Results: Four hundred and seventy-eight patients underwent surgery for thymic malignancies: 40 of them (8.4%) had TC. Eleven (27.5%) received induction chemotherapy because of their radiological invasiveness. A complete resection (R0) was achieved in 36 (90%; 9/11 submitted to induction chemotherapy). Adjuvant radio/chemotherapy was offered to 37 patients, according to the type of surgical resection and tumor invasiveness. Three, 5 and 10-year survival rates were 79%, 75% and 58%. Recurrences developed in 10 patients. R0 resection (p<0.0003) and absence of tumor recurrences (p = 0.03) resulted significant prognostic factors at univariate analysis. Independent CSS predictor was the achievement of a complete resection (p<0.05). Conclusions: TC is a rare and invasive mediastinal tumor. A multimodal approach is indicated especially in TC invasive forms. The achievement of a complete surgical resection is fundamental to improve survival. (C) 2013 Elsevier Ireland Ltd. All rights reserved.
2014
masaoka staging system; thymic carcinoma; outcome; surgery; myasthenia gravis; thymus
01 Pubblicazione su rivista::01a Articolo in rivista
Outcome of surgically resected thymic carcinoma: A multicenter experience / Pier Luigi, Filosso; Francesco, Guerrera; Rendina, Erino Angelo; Angelo Erino, Rendina; Giulia, Bora; Enrico, Ruffini; Domenico, Novero; Ruco, Luigi; Domenico, Vitolo; Anile, Marco; Ibrahim, Mohsen; Caterina, Casadio; Ottavio, Rena; Arianna, Terzi; Paraskevas, Lyberis; Alberto, Oliaro; Venuta, Federico. - In: LUNG CANCER. - ISSN 0169-5002. - STAMPA. - 83:2(2014), pp. 205-210. [10.1016/j.lungcan.2013.11.015]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/552687
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 38
  • ???jsp.display-item.citation.isi??? 39
social impact